Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAA50 | Q9GZZ1 | 2/20 | 0.89 |
| ▸ | CHAT | P28329 | 2/20 | 0.85 |
| ▸ | EP300 | Q09472 | 3/20 | 0.84 |
| ▸ | AURKA | O14965 | 2/20 | 0.84 |
| ▸ | KAT5 | Q92993 | 2/20 | 0.84 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.84 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29378982 | 1.00 | NAA50 (0.89) | NAA50CHATEP300AURKAKAT5 | |
| SCHEMBL27771356 | 1.00 | NAA50 (0.89) | NAA50CHATEP300AURKAKAT5 | |
| SCHEMBL12409230 | 1.00 | NAA50 (0.89) | NAA50CHATEP300AURKAKAT5 | |
| SCHEMBL29238961 | 0.96 | NAA50 (0.88) | NAA50CHATEP300AURKAKAT5 | |
| SCHEMBL30221123 | 0.96 | NAA50 (0.88) | NAA50CHATEP300AURKAKAT5 | |
| SCHEMBL7524149 | 0.96 | NAA50 (0.90) | NAA50CHATEP300AURKAKAT5 | |
| SCHEMBL12018856 | 0.96 | NAA50 (0.90) | NAA50CHATEP300AURKAKAT5 | |
| SCHEMBL30508930 | 0.96 | NAA50 (0.90) | NAA50CHATEP300AURKAKAT5 | |
| SCHEMBL30508932 | 0.96 | NAA50 (0.90) | NAA50CHATEP300AURKAKAT5 | |
| SCHEMBL4657682 | 0.96 | NAA50 (0.82) | NAA50CHATEP300AURKAKAT5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 204 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026101463-A2 | PRODUCTION OF METHACRYLIC ACID AND METHYL-METHACRYLATE VIA CONDENSATION OF ACETONE AND FORMYL-COA | MOJIA BIOTECH PTE. LTD. (SG) | 2026-05-15 | — | — | WO | claimed |
| EP-3362567-B1 | GENETICALLY ENGINEERED BACTERIUM COMPRISING ENERGY-GENERATING FERMENTATION PATHWAY | LANZATECH NZ INC (US) | 2026-05-06 | — | — | EP | claimed |
| US-12577591-B2 | Microorganisms and methods for increasing co-factors | GENOMATICA, INC. (US) | 2026-03-17 | — | — | US | claimed |
| CN-114728871-B | Microorganisms and methods for reducing byproducts | 基因组股份公司 | 2024-12-27 | — | — | CN | claimed |
| US-20220403420-A1 | MICROORGANISMS AND METHODS FOR INCREASING CO-FACTORS | AGAIN BIO APS (DK) | 2022-12-22 | — | — | US | claimed |
| EP-4051657-A1 | MICROORGANISMS AND METHODS FOR REDUCING BY-PRODUCTS | Genomatica, Inc. (US) | 2022-09-07 | — | — | EP | claimed |
| EP-4048781-A1 | MICROORGANISMS AND METHODS FOR INCREASING CO-FACTORS | Genomatica, Inc. (US) | 2022-08-31 | — | — | EP | claimed |
| CN-114901815-A | Microorganisms and methods for increasing cofactors | 基因组股份公司 | 2022-08-12 | — | — | CN | claimed |
| CN-114728871-A | Microorganisms and methods for reducing by-products | 基因组股份公司 | 2022-07-08 | — | — | CN | claimed |
| EP-3688169-A2 | GENETIC KNOCKOUTS IN WOOD-LJUNGDAHL MICROORGANISMS | Lanzatech, Inc. (US) | 2020-08-05 | — | — | EP | claimed |
| EP-2689020-A1 | MICROBIAL PRODUCTION OF CHEMICAL PRODUCTS AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | OPX Biotechnologies Inc. (US) | 2014-01-29 | — | — | EP | claimed |
| US-20130065279-A1 | MICROORGANISMS FOR PRODUCING METHACRYLIC ACID AND METHACRYLATE ESTERS AND METHODS RELATED THERETO | GENOMATICA, INC. (US) | 2013-03-14 | — | — | US | claimed |
| US-20120276604-A1 | MICROORGANISMS FOR THE PRODUCTION OF METHACRYLIC ACID | GENOMATICA, INC. (US) | 2012-11-01 | — | — | US | claimed |
| WO-2012135789-A2 | MICROORGANISMS FOR PRODUCING METHACRYLIC ACID AND METHACRYLATE ESTERS AND METHODS RELATED THERETO | GENOMATICA, INC. (US) | 2012-10-04 | — | — | WO | claimed |
| WO-2012129450-A1 | MICROBIAL PRODUCTION OF CHEMICAL PRODUCTS AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | OPX BIOTECHNOLOGIES, INC. (US) | 2012-09-27 | — | — | WO | claimed |
| JP-2012500641-A | — | — | 2012-01-12 | — | — | JP | claimed |
| US-20110151530-A1 | ENZYMATIC PRODUCTION OF 2-HYDROXY-ISOBUTYRATE (2-HIBA) | METABOLIC EXPLORER (FR) | 2011-06-23 | — | — | US | claimed |
| EP-2331698-A1 | ENZYMATIC PRODUCTION OF 2-HYDROXY-ISOBUTYRATE (2-HIBA) | Metabolic Explorer (FR) | 2011-06-15 | — | — | EP | claimed |
| WO-2010023206-A1 | ENZYMATIC PRODUCTION OF 2-HYDROXY-ISOBUTYRATE (2-HIBA) | METABOLIC EXPLORER (FR) | 2010-03-04 | — | — | WO | claimed |
| WO-2010022763-A1 | METHOD FOR THE PREPARATION OF 2-HYDROXY-ISOBUTYRATE | METABOLIC EXPLORER (FR) | 2010-03-04 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577591-B2 | Microorganisms and methods for increasing co-factors | ABAT, HADHB, MMAB | NAA50 278/4885CHAT 1499/4885EP300 3766/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.